Cartiva, Inc., located in Alpharetta, Georgia, is a private, venture capital-backed company that was spun out from Carticept Medical, Inc. in December 2011. Cartiva is dedicated to improving the quality of life for patients with osteoarthritis or cartilage damage through the development of novel therapies.

An estimated 27 million Americans suffer from osteoarthritis, a chronic degenerative joint disease characterized by the breakdown of the cartilage in the joint. An additional two million Americans injure the cartilage in their knees each year. Many people do not respond well to current medical treatments or are not eligible for major surgery such as a total joint replacement. Cartiva’s mission is to develop and market products to help physicians treat osteoarthritis and cartilage injuries and the related pain more effectively.

Our management team, board of directors and medical advisors are comprised of industry-recognized professionals who possess broad knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials, FDA approval and successful commercialization.

Alpharetta, US
21 (est)+17%
Cartiva was founded in 2011 and is headquartered in Alpharetta, US

Key People at Cartiva

Peter J. Pizzo

Peter J. Pizzo

VP, Finance & CFO
Timothy J. Patrick

Timothy J. Patrick

President, CEO & Board of Directors
Deborah J. Moore

Deborah J. Moore

VP, Regulatory, Quality & Clinical Affairs
Katie E. Strother

Katie E. Strother

Director, Clinical Affairs

Cartiva Locations

Alpharetta, US

Cartiva Metrics

Cartiva Summary

Founding Date


Total Funding

$14.3 M

Latest funding size

$8.5 M

Time since last funding

over 1 year


Cartiva's latest funding round of $8.5 M was in May 2015. In total, Cartiva has raised $14.3 M.
26% of current employees of Cartiva are female and 74% are male.

Cartiva Company Life

You may also be interested in